The coagulopathy specific to APL is known to have a unique pathophysiology, triggered by massive tumor cell lysis, overexpression of procoagulants like annexin II and tissue factor, and characterized by intense hyperfibrinolysis [22]. This evidence concerns the gene ANXA2 and acute promyelocytic leukemia.